At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 25 enrolled
Drug / intervention
Naltrexone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-Blind, Placebo-Controlled Study of Naltrexone in Kleptomania
In Brief
A Phase 2 clinical trial evaluating Naltrexone and Placebo for Kleptomania. Completed, enrolled 25 participants across 1 site.
Detailed Summary
The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in kleptomania.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKleptomania
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMay 2006
First PostedJun 2006
Primary CompletionSep 2008
TodayJul 2026
First PostedJun 1, 2006
Enrollment StartMay 1, 2006
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 20.1 years ago
Interventions
Naltrexonedrug
daily
Placebodrug
daily